Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02669186Enrolling by invitation
Randomised, single-blind trial of fentanyl in pain (2 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Natural Killer Cell Cytotoxicity at 1 year. Started Jul 2019; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02669186.